Lista de obras -

270 Clinical Experience in Allergic Asthma Patients: Omalizumab with Immunotherapy.

artículo científico publicado en 2012

278 Total Antioxidant Capacity, Hydrogen Peroxide, Malondialdehyde and Total Nitric Oxide Concentrations in Patients With Severe Persistent Allergic Asthma: Its Relation to Omalizumab Treatment.

artículo científico publicado en 2012

305 Incidence of Allergy in Patients With Benign Lesions of the Vocal Cords: Preliminary Report.

artículo científico publicado en 2012

426 The Evaluation of Allergen Sensitivity in Food Allergy Patients in Antalya, Turkey.

artículo científico publicado en 2012

481 Differences in Humoral and Cellular Immunity in Young and Old Individuals.

artículo científico publicado en 2012

A case of toxic epidermal necrolysis with diverse etiologies: successful treatment with intravenous immunoglobulin and pulse prednisolone and effects on sTRAIL and sCD200 levels

artículo científico publicado en 2013

Advances in anti-IgE therapy

artículo científico publicado en 2015

Allergic diseases of the skin and drug allergies – 2027. Successful treatment with intravenous immunoglobulin and prednisolone pulse therapy of toxic epidemal necrolysis and Stevens-Johnson Syndrome.

artículo científico publicado en 2013

An overview of the effects of anti-IgE therapies

artículo científico

Association of circulating sTRAIL and high-sensitivity CRP with type 2 diabetic nephropathy and foot ulcers

artículo científico publicado en 2013

Basic and clinical immunology – 3031. The correlation between serum protemics patterns of sTRAIL and CXCL8 with FDG-PET/CT findings in bevacizumab treated colon cancers

Basic and clinical immunology – 3032. 18FDG-PET/CT findings (SUV-MAX) are correlated with survival in stage-4 squamous cell carcinoma

artículo científico publicado en 2013

CD40, CD45 CTLA-4 levels are elevated in healthy older adults

artículo científico publicado el 1 de enero de 2012

CXCL8, IL-1β and sCD200 are pro-inflammatory cytokines and their levels increase in the circulation of breast carcinoma patients

artículo científico publicado en 2016

Circulating Apo 2L levels decreased in genotype II hepatitis C with pegylated interferon-2 alpha treatment.

artículo científico publicado en 2014

Circulating apo 2L levels decreased in hepatitis C with the pegilated interferon-2 alpha treatment

artículo científico publicado en 2015

Circulating soluble apo 2L, soluble OX-2: a possible screening biomarker for stage-4 ovarian, endometrial CA. ⬇️

artículo científico publicado en 2015

Clinical Course and Side Effects of Anti-IgE Monoclonal Antibody in Patients with Severe Persistent Asthma

artículo científico publicado el 1 de enero de 2013

Common variable immunodeficiency syndrome with right aortic arch: a case report

artículo científico publicado en 2004

D-dimer levels decreased in severe allergic asthma and chronic urticaria patients with the omalizumab treatment

artículo científico publicado en 2013

Effects of omalizumab on eosinophil cationic peptide, 25-hydroxyvitamin-D, IL-1βand sCD200 in cases of Samter's syndrome: 36 months follow-up ⬇️

artículo científico publicado el 10 de julio de 2013

Environmental and occupational respiratory diseases – 1039. Clinical course and side effects of anti-IgE monoclonal antibody in patients with severe persistent asthma

artículo científico publicado en 2013

Environmental and occupational respiratory diseases – 1062. The climate and aero allergens in Mediterranean region and allergen sensitivity in allergic rhinoconjuctivitis and allergic asthma patients

Erratum to "IL8 and serum soluble TRAIL levels following anti-VEGF monoclonal antibody treatment in patients with metastatic colon cancer" [Clin. Lab. 2012; 58:501-505].

artículo científico publicado en 2012

Erratum: Circulating Apo 2L levels decreased in genotype II hepatitis C with pegylated interferon-2 alpha treatment

artículo científico publicado en 2016

Evaluation of d-dimer, CXCL8, homocysteine, eosinophil cationic peptide, 25(OH)-vitamin D and immunomodulatory OX-2 levels in allergic patients

artículo científico publicado en 2015

Evaluation of sOX-2 levels in type2 diabetic foot and nephropathic patients: association with disease activity

Evaluation of soluble CD200 levels in type 2 diabetic foot and nephropathic patients: association with disease activity

artículo científico publicado en 2014

Health outcomes, education, healthcare delivery and quality – 3038: The relation of sTRAIL levels and quality of life in omalizumab using severe persistent allergic asthma patients.

artículo científico publicado en 2013

Health outcomes, education, healthcare delivery and quality – 3052. IL-17, IL-18, TGF-beta and GMCSF levels in patients with allergic asthma: Its relation to omalizumab treatment

artículo científico publicado en 2013

High serum soluble CD200 levels in patients with autosomal dominant polycystic kidney disease

artículo científico publicado en 2017

IL-8, IL-10, TGF-β, and GCSF Levels Were Increased in Severe Persistent Allergic Asthma Patients with the Anti-IgE Treatment ⬇️

artículo científico publicado el 19 de diciembre de 2012

IL8 and serum soluble TRAIL levels following anti-VEGF monoclonal antibody treatment in patients with metastatic colon cancer

artículo científico publicado el 1 de enero de 2012

Immunotherapy – 2071. Strail levels decreased after allergen-subcutaneous specific immunotherapy

Increased serum S-TRAIL level in newly diagnosed stage-IV lung adenocarcinoma but not squamous cell carcinoma is correlated with age and smoking

artículo científico publicado en 2013

Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer ⬇️

artículo científico publicado el 7 de febrero de 2012

Level of TNF-related apoptosis-inducing-ligand and CXCL8 correlated with 2-[18F]Fluoro-2-deoxy-D-glucose uptake in anti-VEGF treated colon cancers

artículo científico publicado en 2013

Levofloxacin Induced Toxic Epidermal Necrolysis: Successful Therapy with Omalizumab (Anti-IgE) and Pulse Prednisolone

artículo científico publicado en 2016

Mechanisims of asthma and allergic disease - 1088. Increased serum strail level in newly diagnosed stave-iv lung adenocarcinoma but not sqamous cell carcinoma, is correlated with age and smoking

artículo científico publicado en 2013

Mechanisims of asthma and allergic disease – 1066. Ceruloplasmin oxidase activity in allergic asthma and allergic rhinitis

artículo científico publicado en 2013

Montelukast is as effective as penicillin in treatment of acute otitis media: an experimental rat study

artículo científico publicado en 2013

Omalizumab (anti-IgE) therapy in the asthma-COPD overlap syndrome (ACOS) and its effects on circulating cytokine levels

artículo científico publicado en 2016

Omalizumab (anti-IgE) therapy increases blood glucose levels in severe persistent allergic asthma patients with diabetes mellitus: 18 month follow-up.

artículo científico publicado en 2014

Omalizumab in symptomatic therapy of laryngeal oedema and urticaria attacts in a patient with post operative pulmonary carsinoid tumor

artículo científico publicado en 2015

Omalizumab is effective in treating severe asthma in patients with severe cardiovascular complications and its effects on sCD200, d-dimer, CXCL8, 25-hydroxyvitamin D and IL-1β levels

artículo científico publicado en 2013

Perioperative antibiotic prophylaxis and cost in a Turkish University Hospital

artículo científico publicado en 2007

Pollen aero allergens and the climate in mediterranean region and allergen sensitivity in allergic rhinoconjunctivitis and allergic asthma patients ⬇️

artículo científico publicado el 11 de febrero de 2013

Proteomics pattern of peritoneal sApo-2L but not CD200 (OX-2) as a possible screening biomarker for metastatic ovarian, endometrial and breast carcinoma

artículo científico publicado en 2015

Serum-soluble TRAIL levels in patients with severe persistent allergic asthma: Its relation to omalizumab treatment ⬇️

artículo científico publicado el 1 de marzo de 2012

Soluble TRAIL levels decreased in chronic hepatitis C treatment with pegylated interferon α plus ribavirin: association with viral responses

artículo científico publicado en 2014

Soluble trail as a marker of efficacy of allergen-specific immunotherapy in patients with allergic rhinoconjunctivitis ⬇️

artículo científico publicado el 1 de octubre de 2012

Systemic levels of ceruloplasmin oxidase activity in allergic asthma and allergic rhinitis ⬇️

artículo científico publicado el 28 de junio de 2012

The effects of climate and aero allergens changes in allergic rhinoconjunctivitis and allergic asthma patients in Mediterranean region between 2011 and 2012.

artículo científico publicado en 2013

The relation of sTRAIL levels and quality of life in severe persistent allergic asthma patients using omalizumab

artículo científico publicado el 1 de agosto de 2012

There might be a role for CD200 in the pathogenesis of autoimmune and inflammatory skin disorders

artículo científico publicado en 2013

Total antioxidant capacity, hydrogen peroxide, malondialdehyde and total nitric oxide concentrations in patients with severe persistent allergic asthma: its relation to omalizumab treatment

artículo científico publicado el 1 de enero de 2012

Trimetazidine effect on burn-induced intestinal mucosal injury and kidney damage in rats ⬇️

artículo científico publicado el 15 de septiembre de 2012

Vitamin D serum levels in allergic rhinitis

scholarly article by Sukran Kose et al published 8 April 2015 in The World Allergy Organization Journal

XXIV World Allergy Congress 2015

artículo científico publicado en 2016

Lista de obras de

270 Clinical Experience in Allergic Asthma Patients: Omalizumab with Immunotherapy.

278 Total Antioxidant Capacity, Hydrogen Peroxide, Malondialdehyde and Total Nitric Oxide Concentrations in Patients With Severe Persistent Allergic Asthma: Its Relation to Omalizumab Treatment.

305 Incidence of Allergy in Patients With Benign Lesions of the Vocal Cords: Preliminary Report.

426 The Evaluation of Allergen Sensitivity in Food Allergy Patients in Antalya, Turkey.

481 Differences in Humoral and Cellular Immunity in Young and Old Individuals.

A case of toxic epidermal necrolysis with diverse etiologies: successful treatment with intravenous immunoglobulin and pulse prednisolone and effects on sTRAIL and sCD200 levels

Advances in anti-IgE therapy

Allergic diseases of the skin and drug allergies – 2027. Successful treatment with intravenous immunoglobulin and prednisolone pulse therapy of toxic epidemal necrolysis and Stevens-Johnson Syndrome.

An overview of the effects of anti-IgE therapies

Association of circulating sTRAIL and high-sensitivity CRP with type 2 diabetic nephropathy and foot ulcers

Basic and clinical immunology – 3031. The correlation between serum protemics patterns of sTRAIL and CXCL8 with FDG-PET/CT findings in bevacizumab treated colon cancers

Basic and clinical immunology – 3032. 18FDG-PET/CT findings (SUV-MAX) are correlated with survival in stage-4 squamous cell carcinoma

CD40, CD45 CTLA-4 levels are elevated in healthy older adults

CXCL8, IL-1β and sCD200 are pro-inflammatory cytokines and their levels increase in the circulation of breast carcinoma patients

Circulating Apo 2L levels decreased in genotype II hepatitis C with pegylated interferon-2 alpha treatment.

Circulating apo 2L levels decreased in hepatitis C with the pegilated interferon-2 alpha treatment

Circulating soluble apo 2L, soluble OX-2: a possible screening biomarker for stage-4 ovarian, endometrial CA. ⬇️

Clinical Course and Side Effects of Anti-IgE Monoclonal Antibody in Patients with Severe Persistent Asthma

Common variable immunodeficiency syndrome with right aortic arch: a case report

D-dimer levels decreased in severe allergic asthma and chronic urticaria patients with the omalizumab treatment

Effects of omalizumab on eosinophil cationic peptide, 25-hydroxyvitamin-D, IL-1βand sCD200 in cases of Samter's syndrome: 36 months follow-up ⬇️

Environmental and occupational respiratory diseases – 1039. Clinical course and side effects of anti-IgE monoclonal antibody in patients with severe persistent asthma

Environmental and occupational respiratory diseases – 1062. The climate and aero allergens in Mediterranean region and allergen sensitivity in allergic rhinoconjuctivitis and allergic asthma patients

Erratum to "IL8 and serum soluble TRAIL levels following anti-VEGF monoclonal antibody treatment in patients with metastatic colon cancer" [Clin. Lab. 2012; 58:501-505].

Erratum: Circulating Apo 2L levels decreased in genotype II hepatitis C with pegylated interferon-2 alpha treatment

Evaluation of d-dimer, CXCL8, homocysteine, eosinophil cationic peptide, 25(OH)-vitamin D and immunomodulatory OX-2 levels in allergic patients

Evaluation of sOX-2 levels in type2 diabetic foot and nephropathic patients: association with disease activity

Evaluation of soluble CD200 levels in type 2 diabetic foot and nephropathic patients: association with disease activity

Health outcomes, education, healthcare delivery and quality – 3038: The relation of sTRAIL levels and quality of life in omalizumab using severe persistent allergic asthma patients.

Health outcomes, education, healthcare delivery and quality – 3052. IL-17, IL-18, TGF-beta and GMCSF levels in patients with allergic asthma: Its relation to omalizumab treatment

High serum soluble CD200 levels in patients with autosomal dominant polycystic kidney disease

IL-8, IL-10, TGF-β, and GCSF Levels Were Increased in Severe Persistent Allergic Asthma Patients with the Anti-IgE Treatment ⬇️

IL8 and serum soluble TRAIL levels following anti-VEGF monoclonal antibody treatment in patients with metastatic colon cancer

Immunotherapy – 2071. Strail levels decreased after allergen-subcutaneous specific immunotherapy

Increased serum S-TRAIL level in newly diagnosed stage-IV lung adenocarcinoma but not squamous cell carcinoma is correlated with age and smoking

Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer ⬇️

Level of TNF-related apoptosis-inducing-ligand and CXCL8 correlated with 2-[18F]Fluoro-2-deoxy-D-glucose uptake in anti-VEGF treated colon cancers

Levofloxacin Induced Toxic Epidermal Necrolysis: Successful Therapy with Omalizumab (Anti-IgE) and Pulse Prednisolone

Mechanisims of asthma and allergic disease - 1088. Increased serum strail level in newly diagnosed stave-iv lung adenocarcinoma but not sqamous cell carcinoma, is correlated with age and smoking

Mechanisims of asthma and allergic disease – 1066. Ceruloplasmin oxidase activity in allergic asthma and allergic rhinitis

Montelukast is as effective as penicillin in treatment of acute otitis media: an experimental rat study

Omalizumab (anti-IgE) therapy in the asthma-COPD overlap syndrome (ACOS) and its effects on circulating cytokine levels

Omalizumab (anti-IgE) therapy increases blood glucose levels in severe persistent allergic asthma patients with diabetes mellitus: 18 month follow-up.

Omalizumab in symptomatic therapy of laryngeal oedema and urticaria attacts in a patient with post operative pulmonary carsinoid tumor

Omalizumab is effective in treating severe asthma in patients with severe cardiovascular complications and its effects on sCD200, d-dimer, CXCL8, 25-hydroxyvitamin D and IL-1β levels

Perioperative antibiotic prophylaxis and cost in a Turkish University Hospital

Pollen aero allergens and the climate in mediterranean region and allergen sensitivity in allergic rhinoconjunctivitis and allergic asthma patients ⬇️

Proteomics pattern of peritoneal sApo-2L but not CD200 (OX-2) as a possible screening biomarker for metastatic ovarian, endometrial and breast carcinoma

Serum-soluble TRAIL levels in patients with severe persistent allergic asthma: Its relation to omalizumab treatment ⬇️

Soluble TRAIL levels decreased in chronic hepatitis C treatment with pegylated interferon α plus ribavirin: association with viral responses

Soluble trail as a marker of efficacy of allergen-specific immunotherapy in patients with allergic rhinoconjunctivitis ⬇️

Systemic levels of ceruloplasmin oxidase activity in allergic asthma and allergic rhinitis ⬇️

The effects of climate and aero allergens changes in allergic rhinoconjunctivitis and allergic asthma patients in Mediterranean region between 2011 and 2012.

The relation of sTRAIL levels and quality of life in severe persistent allergic asthma patients using omalizumab

There might be a role for CD200 in the pathogenesis of autoimmune and inflammatory skin disorders

Total antioxidant capacity, hydrogen peroxide, malondialdehyde and total nitric oxide concentrations in patients with severe persistent allergic asthma: its relation to omalizumab treatment

Trimetazidine effect on burn-induced intestinal mucosal injury and kidney damage in rats ⬇️

Vitamin D serum levels in allergic rhinitis

XXIV World Allergy Congress 2015